Bruker Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US1167941087
USD
35.80
0.94 (2.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Penumbra, Inc.
STERIS Plc (Ireland)
Waters Corp.
Insulet Corp.
Hologic, Inc.
Bruker Corp.
Revvity, Inc.
EXACT Sciences Corp.
The Cooper Cos., Inc.
Teleflex, Inc.
Baxter International, Inc.

Why is Bruker Corp. ?

1
High Management Efficiency with a high ROCE of 23.72%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.48 times
3
The company has declared Negative results for the last 5 consecutive quarters
  • OPERATING CASH FLOW(Y) Lowest at USD 134.1 MM
  • ROCE(HY) Lowest at -0.4%
  • RAW MATERIAL COST(Y) Grown by 9.14% (YoY)
4
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -19.53%, its profits have risen by 11.7% ; the PEG ratio of the company is 2.9
5
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
  • Their stake has increased by 6.77% over the previous quarter.
6
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -19.53% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Bruker Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Bruker Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Bruker Corp.
-19.55%
-0.83
53.99%
S&P 500
13.68%
0.71
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
11.57%
EBIT Growth (5y)
-2.22%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
1.48
Net Debt to Equity (avg)
1.06
Sales to Capital Employed (avg)
0.91
Tax Ratio
50.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
23.72%
ROE (avg)
23.45%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
33
Industry P/E
Price to Book Value
2.32
EV to EBIT
29.82
EV to EBITDA
15.71
EV to Capital Employed
1.81
EV to Sales
2.13
PEG Ratio
2.92
Dividend Yield
13.18%
ROCE (Latest)
6.07%
ROE (Latest)
6.95%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

DEBT-EQUITY RATIO (HY)

Lowest at 63.48 %

INVENTORY TURNOVER RATIO(HY)

Highest at 1.69 times

DEBTORS TURNOVER RATIO(HY)

Highest at 5.52 times

OPERATING PROFIT(Q)

Highest at USD 152 MM

OPERATING PROFIT MARGIN(Q)

Highest at 15.55 %

PRE-TAX PROFIT(Q)

Highest at USD 85.8 MM

NET PROFIT(Q)

At USD 33.85 MM has Grown at 76.37%

-6What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD 134.1 MM

ROCE(HY)

Lowest at -0.4%

RAW MATERIAL COST(Y)

Grown by 9.14% (YoY

Here's what is working for Bruker Corp.

Operating Profit
Highest at USD 152 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 15.55 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 85.8 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 33.85 MM has Grown at 76.37%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Debt-Equity Ratio
Lowest at 63.48 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio
Highest at 1.69 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 5.52 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Depreciation
Highest at USD 58.1 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Bruker Corp.

Operating Cash Flow
Lowest at USD 134.1 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Raw Material Cost
Grown by 9.14% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales